HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xingshu Li Selected Research

quinoline

10/2019Development of a Novel Quinoline Derivative as a P-Glycoprotein Inhibitor to Reverse Multidrug Resistance in Cancer Cells.
10/2018Targeting DNA Binding for NF-κB as an Anticancer Approach in Hepatocellular Carcinoma.
1/2018Design, Synthesis, and Evaluation of Orally Bioavailable Quinoline-Indole Derivatives as Innovative Multitarget-Directed Ligands: Promotion of Cell Proliferation in the Adult Murine Hippocampus for the Treatment of Alzheimer's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xingshu Li Research Topics

Disease

43Neoplasms (Cancer)
03/2024 - 05/2015
25Alzheimer Disease (Alzheimer's Disease)
02/2019 - 12/2011
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 12/2019
3Phototoxic Dermatitis (Phototoxicity)
11/2022 - 01/2017
2Neoplasm Metastasis (Metastasis)
01/2022 - 05/2021
2Hypoxia (Hypoxemia)
01/2021 - 01/2018
2Hepatocellular Carcinoma (Hepatoma)
10/2018 - 02/2018
1Stomach Neoplasms (Stomach Cancer)
11/2023
1Glioma (Gliomas)
03/2023
1Fibrosis (Cirrhosis)
05/2022
1Esophageal Neoplasms (Esophageal Cancer)
05/2021
1Skin Neoplasms (Skin Cancer)
05/2021
1Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2021
1Triple Negative Breast Neoplasms
01/2021
1Adenocarcinoma of Lung
01/2021
1Colonic Neoplasms (Colon Cancer)
12/2018

Drug/Important Bio-Agent (IBA)

101-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2022 - 01/2017
10LigandsIBA
02/2019 - 10/2012
7Photosensitizing Agents (Photosensitizers)IBA
03/2023 - 01/2017
6Tacrine (Cognex)FDA Link
01/2019 - 05/2012
5Proteins (Proteins, Gene)FDA Link
03/2024 - 01/2019
5AlbuminsIBA
03/2023 - 01/2019
5TubulinIBA
01/2022 - 01/2017
5ebselenIBA
11/2018 - 11/2013
5AntioxidantsIBA
11/2018 - 10/2012
4Clioquinol (Vioform)FDA Link
02/2019 - 08/2014
4ResveratrolIBA
05/2015 - 12/2012
3Phosphotransferases (Kinase)IBA
03/2024 - 12/2019
3Tyrosine Kinase InhibitorsIBA
11/2023 - 02/2021
3indoleIBA
01/2022 - 01/2017
3quinolineIBA
10/2019 - 01/2018
3Trace Elements (Biometals)IBA
02/2019 - 07/2015
3Cholinesterases (Cholinesterase)IBA
01/2019 - 04/2013
3Tubulin ModulatorsIBA
01/2018 - 01/2016
3Monoamine Oxidase (MAO)IBA
07/2015 - 10/2012
2Reactive Oxygen Species (Oxygen Radicals)IBA
11/2022 - 06/2022
2NitrogenIBA
05/2022 - 10/2018
2biotin receptorIBA
10/2019 - 01/2017
2Doxorubicin (Adriamycin)FDA LinkGeneric
10/2019 - 10/2018
2RoflumilastIBA
02/2019 - 03/2013
2AcetylcholinesteraseIBA
01/2019 - 12/2015
2Glutathione PeroxidaseIBA
11/2018 - 02/2014
2Oxygen (Dioxygen)IBA
02/2018 - 01/2018
2Therapeutic UsesIBA
06/2017 - 01/2017
2SaltsIBA
01/2017 - 01/2016
2Phosphates (Orthophosphate)IBA
01/2017 - 01/2016
2Donepezil (Aricept)FDA LinkGeneric
01/2017 - 11/2013
2Chelating AgentsIBA
02/2016 - 07/2015
2Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA
01/2016 - 07/2015
2MetalsIBA
07/2015 - 10/2012
2Selegiline (E250)FDA LinkGeneric
07/2015 - 04/2013
2Cholinesterase Inhibitors (Anticholinesterases)IBA
02/2014 - 11/2013
2BerberineIBA
05/2012 - 12/2011
1Caspase 3 (Caspase-3)IBA
03/2024
1larotrectinibIBA
11/2023
1tepotinibIBA
11/2023
1zinc(II) phthalocyanine trisulfonic acidIBA
03/2023
1Cysteine (L-Cysteine)FDA Link
03/2023
1ZincIBA
02/2023
1SolutionsIBA
02/2023
1sulfoxideIBA
01/2023
1pyrimidineIBA
01/2023
1SulfonamidesIBA
01/2023
1QuinazolinesIBA
01/2023
14,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA
11/2022
1pirfenidoneIBA
05/2022
1Oxidoreductases (Dehydrogenase)IBA
01/2022
1(1,2- bis(1,2- benzisoselenazolone- 3(2H)- ketone))ethaneIBA
01/2022
1Pemetrexed (MTA)FDA Link
01/2022
1ThioredoxinsIBA
01/2022
1Chalcone (Benzalacetophenone)IBA
01/2022
1AcidsIBA
01/2022
1PyrimidinesIBA
01/2022
1ErbB Receptors (EGF Receptor)IBA
02/2021
1brigatinibIBA
01/2021
1ProdrugsIBA
01/2021
1phthalocyanineIBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Anaplastic Lymphoma KinaseIBA
01/2021
1ceritinibIBA
01/2021
1AQ4NIBA
01/2021
1cytidylyl-(3'-5')-cytidine (CpC)IBA
01/2020
1fluorexon (calcein)IBA
10/2019
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
10/2019
1RolipramIBA
02/2019
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
01/2019
1benzocycloheptapyridineIBA
01/2019
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2019
1Coloring Agents (Dyes)IBA
12/2018

Therapy/Procedure

21Therapeutics
03/2023 - 01/2016
11Photochemotherapy (Photodynamic Therapy)
11/2022 - 01/2017
5Drug Therapy (Chemotherapy)
03/2023 - 10/2019
5Lasers (Laser)
03/2023 - 01/2017
4Photothermal Therapy
05/2021 - 02/2018
3Intravenous Injections
02/2023 - 01/2021
3Phototherapy (Light Therapy)
11/2022 - 11/2020
3Immunotherapy
01/2022 - 01/2021
2Precision Medicine
11/2022 - 06/2017
2Oral Administration
01/2018 - 11/2015
1Transplantation
03/2023